Heidi L. Wagner

CIK: 0001655029

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (37.5%)

Position reduction

Option Exercises (M)3 (37.5%)

Derivative conversions

Awards (A)2 (25.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WVE

Wave Life Sciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

WVE
Wave Life Sciences, Inc.
Oct 5, 2026
Award(A)
Direct
10.7K shares-
WVE
Wave Life Sciences, Inc.
Aug 11, 2026
Exercise(M)
Direct
7K shares at avg. $5.97$42K
WVE
Wave Life Sciences, Inc.
Aug 11, 2026
Sale(S)
Direct
7K shares at avg. $6.01$42K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
7K shares at avg. $5.97$42K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
7K shares at avg. $13.00$91K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Exercise(M)
Direct
7K shares at avg. $5.97$42K
WVE
Wave Life Sciences Ltd.
Dec 8, 2025
Sale(S)
Direct
7K shares at avg. $14.00$98K
WVE
Wave Life Sciences Ltd.
Aug 11, 2025
Award(A)
Direct
12.7K shares-

		Type	Shares	Price		Ownership
Oct 5, 2026	WVE Wave Life Sciences, Inc.	Award(A)	10,700	-	$0	Direct
Aug 11, 2026	WVE Wave Life Sciences, Inc.	Exercise(M)	7,000	$5.97	$41,790	Direct
Aug 11, 2026	WVE Wave Life Sciences, Inc.	Sale(S)	7,000	$6.01	$42,070	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	7,000	$5.97	$41,790	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	7,000	$13.00	$91,000	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Exercise(M)	7,000	$5.97	$41,790	Direct
Dec 8, 2025	WVE Wave Life Sciences Ltd.	Sale(S)	7,000	$14.00	$98,000	Direct
Aug 11, 2025	WVE Wave Life Sciences Ltd.	Award(A)	12,700	-	-	Direct

1-8 of 8 transactions

About Wagner Heidi L

Wagner Heidi L (SEC CIK 0001655029) files insider reports with the SEC as Director of Wave Life Sciences, Inc. (WVE).

Signal8 holds 4 ownership filings by Wagner Heidi L, all Form 4s, filed between Aug 13, 2025 and Oct 7, 2026. Those filings report 8 transactions, from Aug 11, 2025 to Oct 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Wagner Heidi L's filings is in CAMBRIDGE, MA.

Recent filings by Wagner Heidi L

Oct 5, 2026: Grant or award of WVE shares (Form 4, code A).
Aug 11, 2026: Option exercise of WVE shares (Form 4, code M).
Aug 11, 2026: Open-market sale of WVE shares (Form 4, code S).
Dec 8, 2025: Option exercise of WVE shares (Form 4, code M).
Dec 8, 2025: Open-market sale of WVE shares (Form 4, code S).

Other insiders filing for Wave Life Sciences, Inc. (WVE)

RA CAPITAL MANAGEMENT, L.P., Director
Verdine Gregory L., Director
Tan Aik Na, Director
TAKANASHI KEN, Director
CORRIGAN MARK, Director
Rawcliffe Adrian, Director

How to read Form 4 transaction codes